Astragalus for Immune Function

Research suggests that astragalus polysaccharides (APS) may support immune function across a range of contexts, including protection against chemotherapy-induced immune suppression, reactivation of anti-tumor immune cells, restoration of immune balance in inflammatory conditions, and enhancement of both systemic and gut-level immunity in animal models. The body of evidence reviewed here draws primarily from preclinical studies in mice, poultry, livestock, and aquatic species, along with a small number of randomized controlled trials conducted in animals and a clinical evidence mapping review covering gastric cancer patients, meaning that well-controlled human trials directly testing APS for immune function remain limited. Studies indicate that the mechanisms likely involve modulation of gut microbiota, regulation of key inflammatory signaling pathways such as NF-κB and STAT3, and correction of immune cell imbalances, though one review notes that astragalus can exhibit bidirectional effects on immune function depending on factors like dose, processing, and the health status of the recipient. Overall, the existing evidence is directionally consistent and mechanistically plausible, but the predominance of animal and cell-culture data, along with generally low evidence quality noted in clinical reviews, means findings should be interpreted cautiously and do not yet establish clear conclusions for human immune health.